Aksoy, S. Et Al. 2004. Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties. MEDICAL HYPOTHESES , vol.62, no.6 , 942-944.

Aksoy, S., Abali, H., Dincer, M., Kilickap, S., Gullu, I., & Tekuzman, G., (2004). Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties. MEDICAL HYPOTHESES , vol.62, no.6, 942-944.

Aksoy, S Et Al. "Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties," MEDICAL HYPOTHESES , vol.62, no.6, 942-944, 2004

Aksoy, S Et Al. "Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties." MEDICAL HYPOTHESES , vol.62, no.6, pp.942-944, 2004

Aksoy, S. Et Al. (2004) . "Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties." MEDICAL HYPOTHESES , vol.62, no.6, pp.942-944.

@article{article, author={S Aksoy Et Al. }, title={Hypocalcemic effect of zoledronic acid or other bisphosphonates may contribute to their antiangiogenic properties}, journal={MEDICAL HYPOTHESES}, year=2004, pages={942-944} }